A new biotech life sciences building, poised to be a solution for a multitude of companies, is coming to Germantown. Guardian Realty Investors has created Observation Labs, which will offer 67,300 square feet of life science space including spec suites and build-to-suit space when completed.
University of Maryland, Baltimore (UMB) and Wexford Science & Technology, LLC, announced today that 4MLK, the newest development project in the University of Maryland BioPark, is slated to move forward, with groundbreaking this fall (2022) and delivering in summer 2024. The 8-story, 250,000-square-foot building, Phase I of a two-phase project representing a $320 million total capital investment, will provide critical wet laboratory space in downtown Baltimore for researchers and companies, flexible lab and office/support space for start-ups, and Class A office space, along with areas for convening and a conference center.
MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research, as well as next-generation cell therapeutic discovery, development and commercialization, today announced that it has relocated its headquarters to 9713 Key West Avenue in Rockville, Maryland, 20850, within Maryland’s I-270 Biotech Corridor. The Company’s new 67,000 square-foot facility significantly increases its in-house manufacturing capacity, as well as research and process development lab space. This investment represents a major milestone in MaxCyte’s growth and its ability to support customers and partners in their journey through therapeutic development to commercialization.
LuminUltra, the global leader in applied molecular diagnostics, has officially opened its new, state-of-the-art US Headquarters, made up of its Technology Development and Distribution Centers of Excellence.
Texcell – North America , a contract research organization that provides services for biopharmaceutical companies, is growing its U.S. presence with an expansion in Maryland.
The company is adding approximately 27,000 square-feet of laboratory and office space in Frederick and installing new equipment and machinery. When completed, the new facility will contain eight new independent client suites, specifically designed to be flexible based on the project and client needs. Clients will have the opportunity to execute scaled-down manufacturing models, or have the work transferred to a dedicated viral clearance team. The company has started build out construction and is scheduled to be completed in quarter one of 2023.
With this additional space, the company more than doubles its capacity for biosafety testing and viral clearance studies, as well as custom cell culture work . The company has added nearly 20 new jobs since last year and continues to increase its workforce in 2022.
Guardian Realty Investors, LLC announced their new life sciences lab location at 20400 Observation Drive, Germantown MD, known as OBSERVATION LABS. This re-imagined former industrial and technology building will also provide extraordinary amenities, gathering spaces and best-in-class finish levels. Guardian is a developer and operator of office, multi-family and specialized facilities in the Washington, DC Metropolitan Area.
Bisnow recently held a webinar titled “Montgomery County Life Sciences Surge,” sponsored by the Montgomery County Economic Development Corporation (MCEDC), on August 11. Brad Stewart, Senior Vice President of Business Development at MCEDC, posed questions to real estate professional panelists about the future of Montgomery County’s life science environment.
WuXi STA, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), is pleased to announce the groundbreaking for its new 190-acre pharmaceutical manufacturing campus in Middletown, Delaware. First announced in June 2021, this site will be WuXi STA’s second facility in the United States, offering expanded capacity and greater flexibility to meet the needs of customers in the U.S. and around the world.
Venture capital investment into life sciences is slowing, but in the D.C.-area, construction is way up.
The newly minted public company, a clinical-stage provider of cell therapies for cancer and autoimmune diseases, has signed a lease for 60,000 square feet at 800 King Farm Blvd., a roughly 215,000-square-foot office building that Miami-based Banyan Street Capital will convert into office and lab space for life sciences companies. Banyan Street had acquired an ownership stake in 800 King Farm, as well as 700 and 702 King Farm Blvd., in 2020, according to JLL.
